Advances in Diagnostic Techniques for Influenza Virus Infection: A Comprehensive Review
Open Access
- 28 May 2025
- journal article
- review article
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 10 (6) , 152
Abstract
Influenza poses a significant global health burden due to its high transmissibility, antigenic variability, and substantial morbidity. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has further complicated influenza dynamics, highlighting the need for rapid, accurate, and accessible diagnostics. This review comprehensively summarized the advancements in influenza virus (IFV) detection, from conventional methods like viral culture and serology to modern molecular techniques, including CRISPR-based systems, next-generation sequencing (NGS), and biosensors. We analyze the sensitivity, specificity, and applicability of these methods and emphasize their roles in clinical and public health settings. While traditional techniques remain valuable for strain characterization, novel technologies like CRISPR and portable biosensors offer rapid, low-resource solutions. This review provides a comprehensive insight into the development of integrated diagnostic strategies for seasonal IFV epidemics and future pandemics.Keywords
Funding Information
- National Key R&D Program of China (2024YFC2309900, 2022YFC2304400, 2022B1515020075, XKJS-CRGRK-006, LCYSSQ20220823091203007, SZSM202311033)
- National Key Research and Development Program of China (2024YFC2309900, 2022YFC2304400, 2022B1515020075, XKJS-CRGRK-006, LCYSSQ20220823091203007, SZSM202311033)
- Guangdong Basic and Applied Basic Research Foundation (2024YFC2309900, 2022YFC2304400, 2022B1515020075, XKJS-CRGRK-006, LCYSSQ20220823091203007, SZSM202311033)
- Shenzhen Fund for Guangdong Provincial High-level Clinical Key Specialties (2024YFC2309900, 2022YFC2304400, 2022B1515020075, XKJS-CRGRK-006, LCYSSQ20220823091203007, SZSM202311033)
- Shenzhen Clinical Research Center for Emerging Infectious Diseases (2024YFC2309900, 2022YFC2304400, 2022B1515020075, XKJS-CRGRK-006, LCYSSQ20220823091203007, SZSM202311033)
- the Sanming Project of Medicine in Shenzhen (2024YFC2309900, 2022YFC2304400, 2022B1515020075, XKJS-CRGRK-006, LCYSSQ20220823091203007, SZSM202311033)
This publication has 108 references indexed in Scilit:
- Enzyme-Linked Immunosorbent Assay: Types and Applications2023
- Development of a multi‐recombinase polymerase amplification assay for rapid identification of COVID‐19, influenza A and BJournal of Medical Virology, 2022
- Detection of respiratory viruses directly from clinical samples using next‐generation sequencing: A literature review of recent advances and potential for routine clinical useReviews in Medical Virology, 2022
- Enzyme-Linked Immunosorbent Assay (ELISA)2022
- A brief review of influenza virus infectionJournal of Medical Virology, 2021
- Hemagglutination Assay for Influenza Virus2020
- Near‐Infrared Afterglow Semiconducting Nano‐Polycomplexes for the Multiplex Differentiation of Cancer ExosomesAngewandte Chemie International Edition, 2019
- Clinical Interpretation and Implications of Whole-Genome SequencingJAMA, 2014
- The Role of Rapid Antigen Testing for Influenza in the Era of Molecular DiagnosticsMolecular Diagnosis & Therapy, 2010
- Development and evaluation of a real‐time nucleic acid sequence based amplification assay for rapid detection of influenza AJournal of Medical Virology, 2004